0001104659-20-095587.txt : 20200814 0001104659-20-095587.hdr.sgml : 20200814 20200814163335 ACCESSION NUMBER: 0001104659-20-095587 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200812 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duncan Barbara Gayle CENTRAL INDEX KEY: 0001353128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 201105674 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES STREET CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 a4.xml 4 X0306 4 2020-08-12 0 0000722830 IMMUNOMEDICS INC IMMU 0001353128 Duncan Barbara Gayle 62 LAKESHORE DRIVE EASTCHESTER NY 10709 1 0 0 0 Common Stock, $0.01 par value per share 2020-08-12 4 M 0 17077 12.93 A 17077 D Common Stock, $0.01 par value per share 13385 D Stock Option (right to buy) 12.93 2020-08-12 4 M 0 17077 0 D 2020-06-07 2026-06-07 Common Stock, par value $0.01 per share 17077 0 D Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. /s/ Barbara Duncan 2020-08-14